Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis
Authors:
- J. J. SidelmannJSJ. J. Sidelmann
- J. A. SjølandJSJ. A. Sjøland
- J. GramJGJ. Gram
- V. BertelsenVBV. Bertelsen
- T. Mourits‐AndersenTMT. Mourits‐Andersen
- H. MünsterHMH. Münster
- A. M. B. MünsterAMA. M. B. Münster
- J. JespersenJJJ. Jespersen
- 1 January 2007
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 67 (3) , 270-279
Abstract
Lupus anticoagulant (LA) and antiphospholipid antibodies (aPL) are suggested as risk factors for development of deep vein thrombosis (DVT) among patients without systemic lupus erythematosus (SLE). Other conditions, e.g. inflammation, are reported to induce LA and it is uncertain whether the association between LA and DVT is causal. In this study the associations between aPL, LA and inflammation were investigated in 170 consecutive patients without SLE, but with a tentative diagnosis of DVT. DVT was diagnosed in 64 patients. LA was determined according to the criteria of the International Society of Thrombosis and Haemostasis. The concentration of anticardiolipin (aCL) and beta(2)-glycoprotein I (anti-beta(2)-GPI) antibodies as well as C-reactive protein (CRP) was determined with sensitive and precise methods. LA was demonstrated in 8 patients with DVT and in 10 patients without DVT, relative risk 1.33 (CI: 0.55-3.18). No significant association was observed between aCL or anti-beta(2)-GPI and DVT. Patients suffering from DVT had significantly higher concentrations of CRP than patients without DVT. However, CRP was also significantly higher in patients positive for LA than in patients without LA irrespective of the presence of DVT (p<0.001). The present study supports a strong association between inflammatory reactions and development of LA in patients with suspected DVT, whereas no significant association was demonstrated between LA or aPL and DVT.Keywords
This publication has 31 references indexed in Scilit:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- The relationship between inflammation and venous thrombosisThrombosis and Haemostasis, 2005
- Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patientsAnnals of the Rheumatic Diseases, 2004
- Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerationsClinical Immunology, 2004
- Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin AntibodiesMayo Clinic Proceedings, 2004
- Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?British Journal of Haematology, 2003
- Antiphospholipid antibodies and infectionsAnnals of the Rheumatic Diseases, 2003
- The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulantBritish Journal of Haematology, 2000
- Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysisLupus, 1997
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994